Advancements in cellular therapies, biomaterials, and gene-editing tools are transforming how the body’s own repair mechanisms are harnessed. By integrating cutting-edge approaches like CRISPR, stem cell transplantation, and scaffold-based tissue repair, scientists are closing the gap between damage and recovery. Within this dynamic field, regenerative medicine continues to evolve as a solution to chronic diseases and organ failure, replacing traditional methods that focus solely on symptom management. Researchers are now exploring how biological cues and microenvironment modulation can guide tissue regrowth more effectively. Clinical pipelines are expanding rapidly with new trials targeting cartilage regeneration, myocardial repair, and even neural tissue restoration. The potential of regenerative medicine is no longer confined to theoretical constructs—it is being translated into viable therapies with measurable patient outcomes.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : Keratin-TMAO wound dressing promote tissue recovery in diabetic rats via activation of M2 macrophages
Marek Konop, Medical University of Warsaw, Poland
Title : Assessing geometric simplifications in vertebral modeling for reliable numerical analysis of intervertebral discs
Oleg Ardatov, Vilnius University, Lithuania